Antimicrobial susceptibilities of diverse Bacillus anthracis isolates
- PMID: 12435686
- PMCID: PMC132748
- DOI: 10.1128/AAC.46.12.3843-3845.2002
Antimicrobial susceptibilities of diverse Bacillus anthracis isolates
Abstract
A test of 25 genetically diverse isolates of Bacillus anthracis was conducted to determine their susceptibility to seven clinically relevant antimicrobial agents. Etest strips (AB BIODISK, Solna, Sweden) were used to measure the MICs for the isolates. Using the National Committee for Clinical Laboratory Standards MIC breakpoints for staphylococci, three isolates were found to be resistant to penicillin and five were found to be resistant to cefuroxime. The penicillin-resistant isolates were negative for beta-lactamase production. Continued surveillance of B. anthracis field isolates is recommended to monitor antimicrobial susceptibility.
References
-
- Centers for Disease Control and Prevention. 2001. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. Morb. Mortal. Wkly. Rep. 50:909-919. - PubMed
-
- Doganay, M., and N. Aydin. 1991. Antimicrobial susceptibility of Bacillus anthracis. Scand. J. Infect. Dis. 23:333-335. - PubMed
-
- Gold, H. 1967. Treatment of anthrax. Fed. Proc. 26:1563-1568. - PubMed
-
- Isenberg, H. D. (ed.) 1994. Clinical microbiology procedures handbook. Supplement 1. ASM Press, Washington, D.C.
MeSH terms
LinkOut - more resources
Full Text Sources
